An update on endometriosis biomarkers

Area of Science:

• Gynecology
• Biomarker Discovery
• Molecular Diagnostics

Background:

• Endometriosis is a common gynecologic disorder causing chronic pelvic pain, adhesions, and infertility.
• Current diagnosis relies on histology, often leading to delays and significant impacts on quality of life and economy.
• Earlier detection of endometriosis is crucial for improving patient outcomes and reducing morbidity.

Purpose of the Study:

• To review and categorize novel biomarkers for endometriosis diagnosis and prognosis.
• To highlight the potential of microRNAs as diagnostic and prognostic tools for endometriosis.
• To emphasize the need for validated biomarkers to improve early detection rates.

Main Methods:

• Literature review of recent studies on endometriosis biomarkers.
• Categorization of identified biomarkers based on their diagnostic or prognostic potential.
• Focus on emerging data regarding microRNA utility in endometriosis.

Main Results:

• No single biomarker is currently validated for endometriosis diagnosis.
• MicroRNAs show emerging promise for the diagnosis and prognosis of endometriosis disease activity.
• Various novel biomarkers are under investigation for earlier and more accurate detection.

Conclusions:

• Novel biomarkers, particularly microRNAs, hold significant potential for improving endometriosis diagnosis and prognosis.
• Earlier detection through validated biomarkers can enhance patient quality-of-life and minimize economic impact.
• Continued research into endometriosis biomarkers is essential for clinical advancement.